Aeglea BioTherapeutics, Inc. (AGLE)
Company Info
| ISIN | US00773J1034 |
|---|---|
| CUSIP | 00773J103 |
| Sector | Healthcare |
| Industry | Biotechnology |
Trading Data
| Previous Close | $1.27 |
|---|---|
| Year Range | $0.38 - $6.17 |
| EMA (50) | $0.93 |
| EMA (200) | $1.78 |
| Average Volume | $1.64M |
| Market Capitalization | $76.27M |
AGLEShare Price Chart
Loading data...
AGLEPerformance
The chart shows the growth of $10,000 invested in Aeglea BioTherapeutics, Inc. in Apr 2016 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $1,249 for a total return of roughly -87.51%. All prices are adjusted for splits and dividends.
AGLECompare to other instruments
AGLEReturns in periods
| Period | Return | Benchmark |
|---|---|---|
| 1M | 32.61% | 1.45% |
| 6M | -22.29% | -4.82% |
| YTD | -74.32% | -16.96% |
| 1Y | -81.09% | -13.86% |
| 5Y | -21.19% | 8.56% |
| 10Y | -26.90% | 10.51% |
AGLEMonthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | -9.47% | -35.58% | -16.97% | -37.39% | 9.72% | -68.04% | -17.82% | 26.02% | 0.57% | 95.82% | 18.45% | |
| 2021 | -11.69% | 7.19% | 6.31% | -1.77% | -15.04% | 5.30% | -11.93% | 18.27% | 9.66% | -7.92% | -14.75% | -23.88% |
| 2020 | -4.97% | -5.92% | -31.77% | 66.74% | 13.38% | 4.99% | -25.95% | 6.20% | -2.54% | 8.32% | 11.46% | -8.06% |
| 2019 | 22.03% | -8.53% | -3.71% | -14.91% | -8.91% | 9.78% | 30.80% | -12.89% | -1.47% | -1.04% | 12.35% | -10.64% |
| 2018 | 19.78% | 11.88% | 36.83% | -5.85% | 14.35% | -0.94% | -20.51% | 29.96% | -12.44% | -9.82% | -2.43% | -11.05% |
| 2017 | -8.28% | 55.39% | 20.16% | -4.03% | -40.98% | -8.77% | -11.43% | 20.53% | 19.94% | -11.15% | -8.68% | 35.25% |
| 2016 | -10.34% | -14.38% | -35.20% | -1.23% | 17.50% | 13.65% | -16.38% | -3.54% | -15.86% |
AGLEDividend History
Aeglea BioTherapeutics, Inc. doesn't pay dividends
AGLEDrawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
AGLEWorst Drawdowns
The table below shows the maximum drawdowns of the Aeglea BioTherapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the Aeglea BioTherapeutics, Inc. is 96.81%, recorded on Aug 2, 2022. The portfolio has not recovered from it yet.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -96.81% | Apr 11, 2016 | 1589 | Aug 2, 2022 | — | — | — |
AGLEVolatility Chart
Current Aeglea BioTherapeutics, Inc. volatility is 58.51%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.